Immudicon

Immudicon is a biotechnology company that creates complement-based biologics which targets and localizes immune cells to tumors.

Immudicon is a biotechnology company that creates complement-based biologics which targets and localizes immune cells to tumors. The platform modulates chemical barriers within the tumor microenvironment that create an immunosuppressive shield around the tumor. Immudicon was founded in 2011 and is based in Washington, D.C.